Merck
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $15,806,000 | $15,529,000 | $15,624,000 | $16,657,000 |
Gross Profit | 12,249,000 | 12,110,000 | 11,796,000 | 12,577,000 |
EBITDA | 6,423,000 | 7,315,000 | 5,695,000 | 5,606,000 |
EBIT | 5,304,000 | 6,216,000 | 4,498,000 | 4,420,000 |
Net Income | 4,427,000 | 5,079,000 | 3,743,000 | 3,157,000 |
Net Change In Cash | 15,806,000 | 15,529,000 | 15,624,000 | 16,657,000 |
Free Cash Flow | 2,529,000 | 1,172,000 | 2,513,000 | 8,508,000 |
Cash | 8,007,000 | 8,629,000 | 13,242,000 | 14,593,000 |
Basic Shares | 2,513,000 | 2,531,000 | 2,541,000 | 2,541,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $64,168,000 | $60,115,000 | $59,283,000 | $48,704,000 |
Gross Profit | 48,975,000 | 43,989,000 | 41,872,000 | 35,078,000 |
EBITDA | 25,706,000 | 6,907,000 | 21,315,000 | 17,899,000 |
EBIT | 21,207,000 | 3,035,000 | 17,406,000 | 14,685,000 |
Net Income | 17,117,000 | 365,000 | 14,519,000 | 13,049,000 |
Net Change In Cash | 64,168,000 | 60,115,000 | 59,283,000 | 48,704,000 |
Cost of Revenue | 5,016,000 | -202,000 | ||
Free Cash Flow | 18,096,000 | 9,143,000 | 14,707,000 | 9,661,000 |
Cash | 13,242,000 | 6,841,000 | 12,694,000 | 8,096,000 |
Basic Shares | 2,541,000 | 2,547,000 | 2,542,000 | 2,538,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $2.13 |
2025-03-31 | $2.22 |
2024-12-31 | $1.72 |
2024-09-30 | $1.57 |
